AIDS; HIV; advanced HIV; delayed HIV diagnosis; late presentation; risk factors
Abstract :
[en] A late HIV diagnosis is associated with increased mortality and morbidity, increased healthcare costs and increased onward viral transmission. In this regard, we retrospectively analysed the characteristics of patients who presented for care at our centre from January 2018 to December 2022 to assess the proportion of patients and factors associated with late HIV presentation. We collected data from the Liège University Hospital database, and we used binary logistic regression models to analyse the impact of individuals' characteristics on late presentation. Among 167 participants, 38.3% were late presenters (LPs) (presenting for care with a CD4+ T-cell count < 350 cells/mm3 or after an AIDS-defining event), and 21.6% were late presenters with advanced disease (LPs-AD) (presenting for care with a CD4+ T-cell count < 200 cells/mm3 or after an AIDS-defining event). The risk of being an LPs-AD was increased in older individuals (OR on log-transformed age: 7.5) and individuals of sub-Saharan African origin compared to individuals of Belgian or other origin (ORs of 0.30 and 0.25, respectively). The results of this study suggest that broadening the focus beyond the previously common risk groups is essential to prevent late diagnosis.
Disciplines :
Immunology & infectious disease
Author, co-author :
Scaia, Damien; Public Health Science Department, University of Liège, 4000 Liège, Belgium
Maes, Nathalie ; Université de Liège - ULiège > Département des sciences de la santé publique
El Moussaoui, Majdouline ; Université de Liège - ULiège > Département des sciences cliniques > Immunopathologie - Maladies infectieuses et médecine interne générale
Darcis, Gilles ; Université de Liège - ULiège > Département des sciences cliniques
Language :
English
Title :
Risk Factors for Late HIV Presentation in Patients Treated at a Single Belgian Reference Centre from 2018 to 2022.
Martin-Iguacel R. Reyes-Urueña J. Bruguera A. Aceitón J. Díaz Y. Moreno-Fornés S. Domingo P. Burgos-Cibrian J. Tiraboschi J.M. Johansen I.S. et al. Determinants of Long-Term Survival in Late HIV Presenters: The Prospective PISCIS Cohort Study eClinicalMedicine 2022 52 101600 10.1016/j.eclinm.2022.101600
World Health Organization, Regional Office for Europe European Centre for Disease Prevention and Control HIV/AIDS Surveillance in Europe 2021 2020, Data World Health Organization, Regional Office for Europe Geneva, Switzerland European Centre for Disease Prevention and Control Solna, Sweden 2021 Volume 120
Deblonde J. De Rouck M. Montourcy M. Serrien B. Van Beckhoven D. Épidémiologie du SIDA et de L’infection à VIH en Belgique. Situation au 31 Décembre 2020 Rapport 2021 Sciensano Brussels, Belgium 2021
May M.T. Vehreschild J.-J. Trickey A. Obel N. Reiss P. Bonnet F. Mary-Krause M. Samji H. Cavassini M. Gill M.J. et al. Mortality according to CD4 Count at Start of Combination Antiretroviral Therapy among HIV-Infected Patients followed for up to 15 Years after Start of Treatment: Collaborative Cohort Study Clin. Infect. Dis. 2016 62 1571 1577 10.1093/cid/ciw183
The Late Presentation Working Groups in EuroSIDA and COHERE Estimating the Burden of HIV Late Presentation and Its Attributable Morbidity and Mortality across Europe 2010–2016 BMC Infect. Dis. 2020 20 728 10.1186/s12879-020-05261-7
Cohen M.S. Chen Y.Q. McCauley M. Gamble T. Hosseinipour M.C. Kumarasamy N. Hakim J.G. Kumwenda J. Grinsztejn B. Pilotto J.H.S. et al. Prevention of HIV-1 Infection with Early Antiretroviral Therapy N. Engl. J. Med. 2011 365 493 505 10.1056/NEJMoa1105243 21767103
Grabmeier-Pfistershammer K. Rieger A. Schröck T. Schlag M. Economic Burden of Late Presentation in HIV Disease in Austria: A Comparison of the Initial Costs Imposed by Advanced HIV Disease vs. Non-Late Presentation Wien. Klin. Wochenschr. 2013 125 402 407 10.1007/s00508-013-0392-5
Guaraldi G. Zona S. Menozzi M. Brothers T.D. Carli F. Stentarelli C. Dolci G. Santoro A. Da Silva A.R.D. Rossi E. et al. Late Presentation Increases Risk and Costs of Non-Infectious Comorbidities in People with HIV: An Italian Cost Impact Study AIDS Res. Ther. 2017 14 8 10.1186/s12981-016-0129-4 28209189
Krentz H.B. Gill M.J. The Direct Medical Costs of Late Presentation (<350/mm3) of HIV Infection over a 15-Year Period AIDS Res. Treat. 2012 2012 757135 10.1155/2012/757135
Cohen M.S. Chen Y.Q. McCauley M. Gamble T. Hosseinipour M.C. Kumarasamy N. Hakim J.G. Kumwenda J. Grinsztejn B. Pilotto J.H.S. et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission N. Engl. J. Med. 2016 375 830 839 10.1056/NEJMoa1600693
Sagna T. Bisseye C. Compaore T.R. Kagone T.S. Djigma F.W. Ouermi D. Pirkle C.M. Zeba M.T.A. Bazie V.J.T. Douamba Z. et al. Prevention of Mother-to-Child HIV-1 Transmission in Burkina Faso: Evaluation of Vertical Transmission by PCR, Molecular Characterization of Subtypes and Determination of Antiretroviral Drugs Resistance Glob. Health Action 2015 8 26065 10.3402/gha.v8.26065 25630709
Darcis G. Berkhout B. Pasternak A.O. Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs Viruses 2020 12 489 10.3390/v12050489
Darcis G. Berkhout B. Pasternak A.O. The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like Front. Immunol. 2019 10 2251 10.3389/fimmu.2019.02251
Darcis G. Lambert I. Sauvage A.-S. Frippiat F. Meuris C. Uurlings F. Lecomte M. Léonard P. Giot J.-B. Fombellida K. et al. Factors Associated with Late Presentation for HIV Care in a Single Belgian Reference Center: 2006–2017 Sci. Rep. 2018 8 2 10.1038/s41598-018-26852-0
Antinori A. Coenen T. Costagiola D. Dedes N. Ellefson M. Gatell J. Girardi E. Johnson M. Kirk O. Lundgren J. et al. Late Presentation of HIV Infection: A Consensus Definition HIV Med. 2011 12 62 10.1111/j.1468-1293.2010.00857.x
Sun C. Li J. Liu X. Zhang Z. Qiu T. Hu H. Wang Y. Fu G. HIV/AIDS Late Presentation and Its Associated Factors in China from 2010 to 2020: A Systematic Review and Meta-Analysis AIDS Res. Ther. 2021 18 96 10.1186/s12981-021-00415-2
van Wijhe M. Fischer T.K. Fonager J. Identification of Risk Factors Associated with National Transmission and Late Presentation of HIV-1, Denmark, 2009 to 2017 Eurosurveillance 2021 26 2002008 10.2807/1560-7917.ES.2021.26.47.2002008 34823639
Gardner A.T. Napier R. Brown B. Risk Factors for “Late-to-Test” HIV Diagnosis in Riverside County, California Medicine 2016 95 e5021 10.1097/MD.0000000000005021 27684873
Proposal of the Monitoring Committee for a Continued National HIV Plan 2020–2026 with Particular Attention to STI Available online: https://hiv-plan.be/wp-content/uploads/2022/05/Propostion-HIV-Plan-2020-2026_ENG_epidemio.pdf (accessed on 15 July 2022)
Manirankunda L. Loos J. Alou T.A. Colebunders R. Nöstlinger C. “It’s Better Not to Know”: Perceived Barriers to Hiv Voluntary Counseling and Testing among Sub-Saharan African Migrants in Belgium AIDS Educ. Prev. 2009 21 582 593 10.1521/aeap.2009.21.6.582
Liu J. Sun L. Hou Y. Wang L. He Y. Zhou Y. Xu L. Wang H. Wang F. Barriers to Early Diagnosis and Treatment of Severely Immunosuppressed Patients with HIV-1 Infection: A Quantitative and Qualitative Study HIV Med. 2020 21 708 717 10.1111/hiv.13028
Bedert M. Davidovich U. de Bree G. van Bilsen W. van Sighem A. Zuilhof W. Brinkman K. van der Valk M. de Wit J. Understanding Reasons for HIV Late Diagnosis: A Qualitative Study among HIV-Positive Individuals in Amsterdam, The Netherlands AIDS Behav. 2021 25 2898 2906 10.1007/s10461-021-03239-3 33788120
Xu Z. Shen Q. Wang D. Dong Z. Han W. Tian R. Zhou K. Ya X. Hu H. Real-World Data in Late Presentation of HIV Infection in Suzhou, China: Results from Four Consecutive Cross-Sectional Surveys, 2017–2020 Front. Public Health 2023 11 1084840 10.3389/fpubh.2023.1084840
Lauscher P. Hanhoff N. Valbert F. Schewe K. Koegl C. Bickel M. Hoffmann C. Stephan C. Pauli R. Preis S. et al. Socio-Demographic and Psycho-Social Determinants of HIV Late Presentation in Germany—Results from the FindHIV Study AIDS Care 2023 35 1749 1759 10.1080/09540121.2023.2185196
Chone J.S. Abecasis A.B. Varandas L. Determinants of Late HIV Presentation at Ndlavela Health Center in Mozambique Int. J. Environ. Res. Public Health 2022 19 4568 10.3390/ijerph19084568 35457436
Sevgi D.Y. Demirbas N.D. Genc Yaman I. Derin O. Oncul A. Atasoy Tahtasakal C. Gul O. Diktas H. Dokmetas I. Evaluation of the Late Presentation and Associated Factors of People Living with HIV in Turkey J. Med. Virol. 2023 95 e28781 10.1002/jmv.28781
Shi L. Tang W. Liu X. Hu H. Qiu T. Chen Y. Xu X. Chen Y. Zhang Z. Zhou Y. et al. Trends of Late HIV Presentation and Advance HIV Disease among Newly Diagnosed HIV Cases in Jiangsu, China: A Serial Cross-Sectional Study from 2008 to 2020 Front. Public Health 2022 10 1054765 10.3389/fpubh.2022.1054765 36568791
Miranda A.C. Miranda M. Pingarilho M. Pimentel V. Torres J. Peres S. Baptista Alberto T. Gomes P. Abecasis A. Mansinho K. Determinants of HIV-1 Late Presentation in a Cohort of Portuguese HIV-1 Patients AIDS Res. Hum. Retroviruses 2021 37 846 851 10.1089/aid.2020.0175
Otani M. Shiino T. Hachiya A. Gatanaga H. Watanabe D. Minami R. Nishizawa M. Teshima T. Yoshida S. Ito T. et al. Association of Demographics, HCV Co-infection, HIV-1 Subtypes and Genetic Clustering with Late HIV Diagnosis: A Retrospective Analysis from the Japanese Drug Resistance HIV-1 Surveillance Network J. Int. AIDS Soc. 2023 26 e26086 10.1002/jia2.26086
Mukolo A. Villegas R. Aliyu M. Wallston K.A. Predictors of Late Presentation for HIV Diagnosis: A Literature Review and Suggested Way Forward AIDS Behav. 2013 17 5 30 10.1007/s10461-011-0097-6 22218723
Mohammadi Y. Mirzaei M. Shirmohammadi-Khorram N. Farhadian M. Identifying Risk Factors for Late HIV Diagnosis and Survival Analysis of People Living with HIV/AIDS in Iran (1987–2016) BMC Infect. Dis. 2021 21 390 10.1186/s12879-021-06100-z
Hønge B.L. Jespersen S. Aunsborg J. Mendes D.V. Medina C. da Silva Té D. Laursen A.L. Erikstrup C. Wejse C. High Prevalence and Excess Mortality of Late Presenters among HIV-1, HIV-2 and HIV-1/2 Dually Infected Patients in Guinea-Bissau—A Cohort Study from West Africa Pan Afr. Med. J. 2016 25 40 10.11604/pamj.2016.25.40.8329
Arantes L.M.N. Pedroso A.O. Menegueti M.G. Gir E. Botelho E.P. Silva A.C.d.O.E. Reis R.K. Factors Associated with Late Diagnosis of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) in a University Hospital in Brazil: Challenges to Achieving the 2030 Target Viruses 2023 15 2097 10.3390/v15102097
Moussaoui M.E. Lambert N. Maes N. Vaira D. Moutschen M. Darcis G. Impact of the COVID-19 Pandemic Situation on HIV Care in Liège, Belgium HIV Res. Clin. Pract. 2021 22 63 70 34308800
Darcis G. Vaira D. Moutschen M. Impact of Coronavirus Pandemic and Containment Measures on HIV Diagnosis Epidemiol. Infect. 2020 148 e185 10.1017/S0950268820001867 32829742
CHU de Liège Centre de Référence SIDA Available online: https://www.chuliege.be/jcms/c2_17345654/fr/centre-de-reference-sida/accueil (accessed on 6 August 2023)
